loading
Schlusskurs vom Vortag:
$2.48
Offen:
$2.47
24-Stunden-Volumen:
108.33K
Relative Volume:
1.11
Marktkapitalisierung:
$25.66M
Einnahmen:
$1.65M
Nettoeinkommen (Verlust:
$-5.66M
KGV:
-2.1356
EPS:
-1.18
Netto-Cashflow:
-
1W Leistung:
-10.00%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$2.36
$2.59
1-Wochen-Bereich:
Value
$2.36
$3.0837
52-Wochen-Spanne:
Value
$2.36
$14.09

20 20 Biolabs Inc Stock (AIDX) Company Profile

Name
Firmenname
20 20 Biolabs Inc
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
AIDX's Discussions on Twitter

Compare AIDX vs ABT, SYK, MDT, BSX, EW

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
AIDX
20 20 Biolabs Inc
2.48 25.66M 1.65M -5.66M 0 -1.18
Medical Devices icon
ABT
Abbott Laboratories
108.01 187.91B 44.33B 6.50B 7.40B 3.717
Medical Devices icon
SYK
Stryker Corp
340.95 129.05B 25.12B 3.25B 4.28B 8.3984
Medical Devices icon
MDT
Medtronic Plc
87.42 112.19B 35.48B 4.64B 5.41B 3.582
Medical Devices icon
BSX
Boston Scientific Corp
68.68 101.72B 20.08B 2.89B 3.66B 1.9391
Medical Devices icon
EW
Edwards Lifesciences Corp
82.11 49.14B 6.07B 1.06B 1.34B 1.8063

20 20 Biolabs Inc Aktie (AIDX) Neueste Nachrichten

pulisher
Mar 12, 2026

20/20 BioLabs provides update on protein biomarket technology for MCED - TipRanks

Mar 12, 2026
pulisher
Mar 12, 2026

20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent Studies - Bitget

Mar 12, 2026
pulisher
Mar 10, 2026

Jonathan Cohen Discloses Investment at 20/20 Biolabs with 16.8% Stake - TradingView

Mar 10, 2026
pulisher
Mar 04, 2026

20/20 Biolabs Inc. (AIDX) Revenue (Quarterly) Yoy Growth - Zacks Investment Research

Mar 04, 2026
pulisher
Mar 04, 2026

20/20 Biolabs (AIDX) 10K Form and SEC Filings 2026 - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Mar 04, 2026
pulisher
Mar 04, 2026

20/20 Biolabs Inc. (AIDX) Price To Cash Flow - Zacks Investment Research

Mar 04, 2026
pulisher
Mar 03, 2026

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Mar 03, 2026
pulisher
Mar 03, 2026

20/20 Biolabs Inc. (AIDX) Net Income (Quarterly) - Zacks Investment Research

Mar 03, 2026
pulisher
Mar 03, 2026

AIDX News Today | Why did 20/20 Biolabs stock go down today? - MarketBeat

Mar 03, 2026
pulisher
Mar 03, 2026

20/20 Biolabs (AIDX) Stock Price, News & Analysis - MarketBeat

Mar 03, 2026
pulisher
Mar 02, 2026

20/20 Biolabs Inc. (AIDX) Cash From Operations (TTM) - Zacks Investment Research

Mar 02, 2026
pulisher
Mar 02, 2026

Number of employees of 20/20 Biolabs, Inc. – NASDAQ:AIDX - TradingView

Mar 02, 2026
pulisher
Mar 02, 2026

20/20 Biolabs Inc. (AIDX) Cash From Financing (TTM) - Zacks Investment Research

Mar 02, 2026
pulisher
Mar 02, 2026

20/20 Biolabs Inc. (AIDX) Dividend Yield (TTM) - Zacks Investment Research

Mar 02, 2026
pulisher
Mar 02, 2026

20/20 Biolabs Inc. (AIDX) Shareholders Equity (Quarterly) - Zacks Investment Research

Mar 02, 2026
pulisher
Mar 02, 2026

20/20 Biolabs Inc. (AIDX) Revenue (Quarterly) - Zacks Investment Research

Mar 02, 2026
pulisher
Mar 02, 2026

20/20 Biolabs Inc. (AIDX) Profit Margin (Quarterly) - Zacks Investment Research

Mar 02, 2026
pulisher
Mar 01, 2026

20/20 Biolabs Inc. (AIDX) Revenue (TTM) - Zacks Investment Research

Mar 01, 2026
pulisher
Mar 01, 2026

20/20 Biolabs Inc. (AIDX) - Zacks Investment Research

Mar 01, 2026
pulisher
Mar 01, 2026

20/20 Biolabs Inc. (AIDX) Total Assets (Quarterly) - Zacks Investment Research

Mar 01, 2026
pulisher
Mar 01, 2026

20/20 Biolabs Inc. (AIDX) Ps Ratio (TTM) - Zacks Investment Research

Mar 01, 2026
pulisher
Feb 28, 2026

20/20 Biolabs, Inc. Common Stock (AIDX) Competitors - Meyka

Feb 28, 2026
pulisher
Feb 28, 2026

20/20 Biolabs, Inc. Common Stock (AIDX) AI-Powered Stock Analysis - Meyka

Feb 28, 2026
pulisher
Feb 28, 2026

AIDX News Today: Stay Updated with the Latest 20/20 Biolabs, Inc. Common Stock News in Real Time - Meyka

Feb 28, 2026
pulisher
Feb 28, 2026

Why Is 20/20 Biolabs, Inc. Common Stock (AIDX) Stock Up Today? - Meyka

Feb 28, 2026
pulisher
Feb 28, 2026

20/20 Biolabs, Inc. Common Stock (AIDX) Fundamental Analysis - Meyka

Feb 28, 2026
pulisher
Feb 27, 2026

What is the current Price Target and Forecast for 20/20 Biolabs Inc. (AIDX) - Zacks Investment Research

Feb 27, 2026
pulisher
Feb 26, 2026

Operating income of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Non-operating income (total) of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Diluted earnings per share (diluted EPS) of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Net income before discontinued operations of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

AIDX Price History for 20/20 Biolabs Stock - Barchart.com

Feb 26, 2026
pulisher
Feb 26, 2026

Non-controlling/minority interest of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Equity in earnings of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Taxes of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Operating expenses (excl. COGS) of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Diluted net income available to common stockholders of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

After tax other income/expense of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Gross profit of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Dilution adjustment of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Pretax income of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Feb 26, 2026
pulisher
Feb 26, 2026

Total liabilities of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Total debt of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Total liabilities & shareholders' equities of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Net debt of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Total equity of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

20/20 Biolabs, Inc. Cash Flow – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Total assets of 20/20 Biolabs, Inc. – BOATS:AIDX - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

20/20 Biolabs, Inc. Balance Sheet – BOATS:AIDX - TradingView

Feb 26, 2026

Finanzdaten der 20 20 Biolabs Inc-Aktie (AIDX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices ZBH
$93.37
price up icon 0.81%
medical_devices STE
$214.68
price up icon 0.97%
$64.99
price down icon 0.75%
medical_devices PHG
$27.89
price down icon 1.45%
$70.74
price up icon 0.64%
medical_devices EW
$82.25
price down icon 3.02%
Kapitalisierung:     |  Volumen (24h):